ScienceDex / Researcher record
Vachon, Tracy
- Charles River Laboratories Intntl, Inc. (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 5% Funded
- Early Career
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $5,843,562 | 1 | #551 |
| 2022 | $12,463,375 | 4 | #173 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2021 · selected1 record
- FY20224 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Vachon, Tracy as a PI. Multi-PI records show the full award amount for context.
- 271201600001I-0-759502100001-1N01Contact PIDEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC OF A MULTIGENOTYPIC AGED MOUSE COLONY PERIOD OF PERFORMANCE MARCH 14, 2021 - MARCH 13, 2022$5.8Maward amount
Award organization
Organizations that administered FY2021 awards listing Vachon, Tracy as a PI.
FY2021 award administered by Charles River Laboratories Intntl, Inc. (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardCharles River Laboratories Intntl, Inc.
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021$5M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #551
- 2021Entered Top 25% NationallyRanked #551
- 2021Entered Top 10% NationallyRanked #551
- 2021Entered Top 5% NationallyRanked #551
- 2022$10M Cumulative Funding
- 2022Entered Top 1% NationallyRanked #173